发明名称 IMIDAZOPYRIMIDINYL AND IMIDAZOPYRIDINYL DERIVATIVES
摘要 Provided herein are compounds of formula (I): wherein D is an aryl or heteroaryl ring containing 1 - 2 C1-4 haloalkoxy groups; as well as stereoisomers and pharmaceutically acceptable salts thereof. Such compounds are, because of their ability to antagonize CRF, useful in the treatment of a variety of disorders characterized by excessive CRF expression. These include, for example: affective disorder, anxiety, depression, headache, irritable bowel syndrome, post-traumatic stress disorder, supranuclear palsy, immune suppression, Alzheimer's disease, Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis, gastrointestinal diseases, anorexia nervosa or other feeding disorder, drug addiction, drug or alcohol withdrawal symptoms, inflammatory diseases, cardiovascular or heart-related diseases, fertility problems, human immunodeficiency virus infections, hemorrhagic stress, obesity, infertility, head and spinal cord traumas, epilepsy, stroke, ulcers, amyotrophic lateral sclerosis and hypoglycemia.
申请公布号 WO0144248(A1) 申请公布日期 2001.06.21
申请号 WO2000US34201 申请日期 2000.12.15
申请人 DU PONT PHARMACEUTICALS COMPANY 发明人 WILDE, RICHARD, G.;BAKTHAVATCHALAM, RAJAGOPAL;BECK, JAMES, P.;ARVANITIS, ARGYRIOS
分类号 A61K31/437;A61K31/52;A61P1/00;A61P1/04;A61P1/14;A61P3/04;A61P3/08;A61P9/00;A61P9/10;A61P21/02;A61P25/00;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/32;A61P29/00;A61P37/04;C07D471/04;C07D473/00;(IPC1-7):C07D473/00;A61K31/505 主分类号 A61K31/437
代理机构 代理人
主权项
地址